Hepatobiliary Surgery

The Department of Hepatobiliary Surgery at the First Affiliated Hospital of Dalian Medical University is a key discipline in Liaoning Province and a discipline of particular strength at our hospital. The Department is an institution authorized to confer doctoral degrees and currently has 1 national committee member of the Surgery Branch of the Chinese Medical Association and 2 members of national surgical groups. Four members also serve on the editorial boards of journals in the Chinese Medical series and national core journals. Professor Wang Zhongyu, a national committee member of the Surgery Branch of the Chinese Medical Association and recipient of the Chinese Physician Award, is the academic leader. In recent years, the discipline has received funding for 6 projects from the National Natural Science Foundation of China, 4 provincial- and ministerial-level science funds, and 2 Dalian Municipal Science Funds. It has received 1 second prize and 6 third prizes for provincial- and ministerial-level scientific and technological progress, and has published 7 SCI-indexed papers and more than 50 papers in core journals.

Our department currently has 10 experts with senior professional titles, 3 doctoral supervisors, and 30% of the nursing team hold bachelor's degrees. In the fields of surgical diagnosis and treatment, scientific research, and clinical nursing for tumors of the liver, biliary tract, and pancreas, it has reached a leading level in Dalian and an advanced level nationally.

The department can now independently perform combined three-lobe hepatectomy, RO radical resection for hilar cholangiocarcinoma, complex anatomical pancreaticoduodenectomy, middle pancreatectomy, and total pancreatectomy, among other procedures. It has become the hepatobiliary and pancreatic tumor surgical treatment center with the highest diagnostic and treatment standards in southern Liaoning. In recent years, techniques including precise hepatic segmentectomy for liver cancer, anatomical resection for pancreatic cancer, and laparoscopic resection of the biliary tract and liver have improved markedly. Subspecialty outpatient clinics for tumors of the liver, biliary tract, and pancreas have also been established. The Department of Hepatobiliary and Pancreatic Surgery has developed extensive cooperation with renowned medical centers worldwide. Several physicians have been sent for advanced training at hepatobiliary and laparoscopic medicine centers at renowned universities in Germany, the United States, and other countries. Within China, long-term friendly cooperative relationships have been established with institutions such as Zhongshan Hospital of Fudan University and Tongji Hospital. These collaborations have played an important role in improving the clinical skills of our future clinical personnel and advancing basic research.

Over the next 3 years, our department will collaborate with the stem-cell tumor therapy research of the China–UK Regenerative Clinical Application Center under the Ministry of Science and Technology to strengthen biological therapy for hepatobiliary and pancreatic tumors. Advanced equipment will be updated and introduced in a timely manner so that the overall level of the medical environment and equipment remains at the leading level in China. The department will attain an internationally advanced level in the treatment of hepatobiliary and pancreatic tumors and in the development of information technology for the specialty.